Proteomic analysis in brains of CLN1-, CLN2- and CLN3-animal models detected a considerably smaller number of changes in protein expression at terminal stages of these genetic disorders than the magnitude of DEGs detected by our study, perhaps due in part to the limited sensitivity of proteomic analyses [95]. Here, CLN3 is linked to hereditary disease.